[Optimal drug therapy of glucose intolerance is a guarantee of successful prevention of type 2 diabetes mellitus].
Mkrtumian
A M
AM
D020909:Acarbose / Q000627:therapeutic use*; D000328:Adult; D000367:Age Factors; D000368:Aged; D001786:Blood Glucose / Q000032:analysis; D015992:Body Mass Index; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000378:metabolism / Q000517:prevention & control*; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005934:Glucagon / Q000097:blood; D005947:Glucose / Q000378:metabolism; D018149:Glucose Intolerance / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000097:blood; D008019:Life Style; D008875:Middle Aged; D015337:Multicenter Studies as Topic; D010919:Placebos; D012307:Risk Factors; D000074606:Smoking Prevention
D001786:Blood Glucose; D004791:Enzyme Inhibitors; D007004:Hypoglycemic Agents; D007328:Insulin; D010919:Placebos; D005934:Glucagon; D005947:Glucose; D020909:Acarbose